IMC Responds to Final Report of Advisory Council on the Implementation of National Pharmacare
OTTAWA, ON / ACCESSWIRE / June 12, 2019 / The recommendations put forward today by the Advisory Council on the...
user
EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.
VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into 20...
Schlomo Schmuel Proudly Announces the Winners of Scholarship Program for Post-Secondary Academic Achievement
Schlomo Schmuel, DPM is a Podiatrist and with nearly 27 years of experience as a specialized podiatric doctor, with the...
Aytu BioScience Featured in Local NBC News Segment (VIDEO): ”Nasal Spray for Low Testosterone Preserves Fertility”
ENGLEWOOD, CO / ACCESSWIRE / June 12, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
Hemogenyx Pharmaceuticals PLC Announces CDX Effective as Conditioning Therapeutic in vivo
CDX Antibody is Effective as Conditioning Therapeutic in vivo LONDON, UK / ACCESSWIRE / June 12, 2019 / Hemogenyx Pharmaceuticals...
Fortifeye’s Super Omega-3 Max the Most Potent Omega-3 Supplement in the Industry
Fifty percent more potent than Fortifeye's previous Super Omega, the Super Omega-3 Max is the new industry leader OCALA, FL...
Spherix Inc. (NasdaqCM: SPEX) Trading Below Book Value; Diversified Asset Base Adds Value
Spherix's investment portfolio into emerging biotech stocks has resulted in substantial gains, turning a roughly $860,000 investment into a position...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-end Financial Results on June 17, 2019
Financials for Fiscal Year Ended March 31, 2019 will be released June 14, 2019 NORTHVALE, NJ / ACCESSWIRE / June...
Viveve to Present at Raymond James Life Sciences and MedTech Conference
ENGLEWOOD, CO / ACCESSWIRE / June 11, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on...
Virpax(R) Pharmaceuticals Announces Appointment of Michèle C. Linde, EVP, General Counsel
MALVERN, PA / ACCESSWIRE / June 11, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products...
Aytu BioScience Set to Join Russell Microcap (R) Index
ENGLEWOOD, CO / ACCESSWIRE / June 11, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication
SAN FRANCISCO, CA / ACCESSWIRE / June 11, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’
SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused...
GeneNews Signs Global Licensing and Services Agreement with Oncore Pharma
TORONTO, ON / ACCESSWIRE / June 10, 2019 / GeneNews Limited (TSX: GEN), a life sciences company specializing in blood-based...
Milestone Scientific’s CompuFlo(R) Epidural Instrument Featured in Multiple Abstracts at Euroanaesthesia 2019
Madrid hospital finds CompuFlo a reliable technique for blood patch procedures European School of Obstetric Anesthesia reports CompuFlo improves trainee...
CTD Announces Continuation of Expanded Access Program in Single Alzheimer’s Patient
Favorable risk/benefit analysis outlined in report to FDA ALACHUA, FL / ACCESSWIRE / June 10, 2019 / CTD Holdings, Inc....
New Jersey Lasik Surgeon Dr. Steven W. Stetson Returns to Paramus for Patient Surgeries
Dr. Stetson, Who is Medical Director of Diamond Vision, is Again Seeing Patients and Performing Surgery at the Paramus Office...
David Appell Joins Parallax Health Sciences, Inc. as Chief Operating Officer
Mr. Appell brings over twenty years of experience in building high volume transactional-related platforms to deliver large revenue streams SANTA...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019
Parnell Delivers 9% Revenue Growth in Quarter 1 of 2019 Compared to 2018, and Confirms Provisional 2019 Guidance for a...
DECN Discusses Propositions Received For Its GenUltimate TBG
LOS ANGELES, CA / ACCESSWIRE / June 7, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...